Cadaver-donor renal retransplants.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 7918181)

Published in Clin Transpl on January 01, 1993

Authors

Y W Cho, J M Cecka

Articles citing this

Results of renal re-transplant in Spain (1990-2002). NDT Plus (2010) 0.75

Articles by these authors

High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med (1995) 5.41

Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48

The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13

Oral delivery of insulin. Lancet (1990) 2.13

Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12

Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09

Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation (1998) 1.78

Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65

The hyperfiltration hypothesis in human renal transplantation. Transplantation (1994) 1.63

Living unrelated donor kidney transplantation. Kidney Int (2000) 1.61

Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58

Structure of murine Ia antigens: partial NH2-terminal amino acid sequences of products of the I-E or I-C subregion. Proc Natl Acad Sci U S A (1977) 1.56

Expanding the donor kidney pool: utility of renal allografts procured in a setting of uncontrolled cardiac death. Am J Transplant (2006) 1.53

Paired kidney exchange is not a solution to ABO incompatibility. Transplantation (1998) 1.43

Analyses of the UNOS Scientific Renal Transplant Registry at three years--early events affecting transplant success. Transplantation (1992) 1.37

Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology (2001) 1.36

Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33

Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med (2000) 1.18

The effect of race and ethnicity on kidney allograft outcome. Clin Transpl (1995) 1.18

Pharmacologic potency and selectivity of a new bronchodilator agent: soterenol (MJ 1992). J Pharmacol Exp Ther (1968) 1.17

Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study. Am J Transplant (2010) 1.14

Chemical characterization of products of the H-2 complex. Cold Spring Harb Symp Quant Biol (1977) 1.11

Peptide map analyses of murine Ia antigens of the I-E subregion using HPLC. Nature (1979) 1.10

Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study. Am J Transplant (2009) 1.10

Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation (2000) 1.09

The UNOS Scientific Renal Transplant Registry. Clin Transpl (1999) 1.04

Visceral fat amount is associated with carotid atherosclerosis even in type 2 diabetic men with a normal waist circumference. Int J Obes (Lond) (2008) 1.04

Nasal decongestant activity of pseudoephedrine. Ann Otol Rhinol Laryngol (1977) 1.02

Kidney paired donation in the presence of donor-specific antibodies. Kidney Int (2013) 1.01

Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients. Transplantation (1998) 1.01

Partial N-terminal amino acid sequence analyses and comparative tryptic peptide maps of murine Ia molecules encoded by the I-A subregion. Eur J Immunol (1979) 1.00

Risk rate and long-term kidney transplant survival. Clin Transpl (1996) 0.98

Should pediatric patients wait for HLA-DR-matched renal transplants? Am J Transplant (2008) 0.97

Determinants of long-term survival of pediatric kidney grafts reported to the United Network for Organ Sharing kidney transplant registry. Pediatr Transplant (2001) 0.96

Effect of delayed graft function on short- and long-term kidney graft survival. Clin Transpl (1997) 0.95

Cytomegalovirus antibody status and renal transplantation: 1987-1994. Transplantation (1996) 0.92

Effect of dietary Platycodon grandiflorum on the improvement of insulin resistance in obese Zucker rats. J Nutr Biochem (2000) 0.91

Patient death after renal transplantation--an analysis of its role in graft outcome. Transplantation (1996) 0.91

Significance of the donor age effect on kidney transplants. Clin Transplant (1997) 0.91

The UNOS Scientific Renal Transplant Registry--2000. Clin Transpl (2000) 0.90

Strategy for eliminating the kidney shortage. Clin Transpl (1997) 0.90

Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival. Transplantation (1994) 0.90

Why are nearly half of expanded criteria donor (ECD) kidneys not transplanted? Am J Transplant (2007) 0.89

Structural aspects of immune recognition of lysozymes. III. T cell specificity restriction and its consequences for antibody specificity. Eur J Immunol (1976) 0.88

Crossmatch tests--an analysis of UNOS data from 1991-2000. Clin Transpl (2001) 0.88

Fifteen-year kidney graft survival. Clin Transpl (1989) 0.88

Outcome of renal transplantation in blacks. Transplant Proc (1987) 0.87

Pharmacology of a new antianginal drug: perhexiline. I. Coronary circulation and myocardial metabolism. Chest (1970) 0.87

Nodulus infarction mimicking acute peripheral vestibulopathy. Neurology (2003) 0.87

Kidney transplantation in children and adolescents: an analysis of United Network for Organ Sharing Database. Transplant Proc (2009) 0.85

The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor. Transplantation (1996) 0.85

The UNOS Scientific Renal Transplant Registry. Clin Transpl (1998) 0.85

Clinical aspects of sensitization. Clin Transpl (1997) 0.85

Pharmacology of a new antianginal drug: perhexiline. 3. Bronchopulmonary system in the dog and humans. Chest (1970) 0.85

Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing. Transplantation (2000) 0.84

Modulation of natural killer cell activity affected by electroacupuncture through lateral hypothalamic area in rats. Neurosci Lett (2002) 0.84

Nitroimidazoles in the treatment of trichomoniasis, giardiasis, and amebiasis. Int J Clin Pharmacol Ther Toxicol (1984) 0.83

Primary disease effects and associations in patients without early posttransplant events. Clin Transpl (1995) 0.83

The UNOS Scientific Renal Transplant Registry. United Network for Organ Sharing. Clin Transpl (1994) 0.83

Structure of Ia antigens from the rat. Mouse alloantisera demonstrate at least two distinct molecular species. Eur J Immunol (1980) 0.82

The UNOS Scientific Renal Transplant Registry. Clin Transpl (1996) 0.82

Partial N-terminal amino acid sequence of rat transplantation antigens. Nature (1978) 0.82

Sensitization in renal transplantation. Clin Transpl (1991) 0.82

The great success of Asian kidney transplant recipients. Transplantation (1997) 0.82

Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase. J Clin Pharmacol (1981) 0.81

Center effects in renal transplantation. Clin Transpl (1991) 0.81

Immunosuppressive regimens and their effects on renal allograft outcome. Clin Transpl (1996) 0.81

Direct cardiac action of E. coli endotoxin. Proc Soc Exp Biol Med (1972) 0.81

A double-blind, placebo-controlled evaluation of (dl)-3,7-dihydro-1,8-dimethyl-3-(2-methylbutyl)-1H-purine-2,6-dione in exercise-induced bronchospasm. Int J Clin Pharmacol Ther Toxicol (1981) 0.81

New variables reported to the UNOS registry and their impact on cadaveric renal transplant outcomes - a preliminary study. Clin Transpl (1995) 0.80

5-HT1A receptor-mediated activation of G-protein-gated inwardly rectifying K+ current in rat periaqueductal gray neurons. Neuropharmacology (2001) 0.80

A ten-year prediction for kidney transplant survival. Clin Transpl (1992) 0.80

UCLA and UNOS Registries. Overview. Clin Transpl (1991) 0.80

Inhibitory effects of electroacupuncture on stress responses evoked by tooth-pulp stimulation in rats. Physiol Behav (1999) 0.80

Should excessive height and weight differences between the kidney donor and recipient be avoided? Transplant Proc (1997) 0.80

Clinical Pharmacology for Pediatricians. II. Antisickling agents, with special reference to new vasoerythroactive drugs. J Clin Pharmacol (1982) 0.80

Quantitative correlation of plasma and myocardial quinidine concentrations with biochemical and electrocardiographic changes. Am Heart J (1973) 0.80

Race effects. Clin Transpl (1991) 0.80

The center effect: is bigger better? Clin Transpl (1999) 0.80

Prolonged hypertension (> 10 years) is a significant risk factor in older cadaver donor renal transplants. Transplant Proc (1999) 0.80

A report from the UNOS Scientific Renal Transplant Registry. Transplant Proc (1991) 0.79

The UNOS Scientific Renal Transplant Registry--1991. Clin Transpl (1991) 0.79

Antibody production to antigen-specific factors. Contemp Top Immunobiol (1980) 0.79

The transfusion effect in cadaver kidney transplants--yes or no. Transplantation (1990) 0.79

Center effect in the UNOS Renal Transplant Registry. Clin Transpl (1992) 0.79

Early rejection episodes. Clin Transpl (1989) 0.79

Impact analysis: a method for evaluating the impact of factors in clinical renal transplantation. Clin Transpl (1998) 0.78

High kidney graft survival rates using non-heart-beating trauma donors. Transplant Proc (1998) 0.78

Donor factors. Clin Transpl (1994) 0.78

Advances in kidney transplantation: 1985-1995. Clin Transpl (1995) 0.78

Long-term graft survival. Clin Transpl (1990) 0.78